Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Astellas Looks To India As Part Of Japanese Drug Maker Trend

This article was originally published in PharmAsia News

Executive Summary

Astellas Pharma of Japan is considering becoming active in India as Japanese drug makers look to that country to expand sales and manufacture their products. A consultant said Japanese companies increasingly are looking to expand in India because the country is particularly suitable for pharmaceutical and chemical companies. Daiichi Sankyo is buying Ranbaxy Laboratories, Eisai already is expanding manufacturing and sales operations into India, both an indication the trend is likely to accelerate. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts